ʻO nā lāʻau hōʻemi no ka hoʻohaʻahaʻa i ke koko koko i ka maʻi diabetes

Koho ʻia nā peni no ka maʻi lolo ma muli o ke ʻano o ka maʻi, i hoʻokaʻawale ʻia i ke ʻano he 2: hilinaʻi o ka insulin a ʻaʻole i koi ʻia ka hoʻomaka ʻana o ka insulin. Ma mua o ka hoʻomaka ʻana i ka mālama ʻana, e noiʻi i ka hoʻonohonoho ʻana o nā waiʻaila e hoʻohiolo ana i ka wai, ke ʻano o ka hana o kēlā me kēia hui a me nā contraindications no ke hoʻohana.

ʻO ka lawe ʻana i nā paila he mea nui ia o ke ola maʻi.

ʻO ka papahele ʻana o nā papa no ka maʻi maʻi

ʻO ke kumumanao o ka mālama hānaiʻana, ʻo ia ka mālama i ka kōʻai i ka pae kiʻekiʻe o 4-5-5.5 mmol / L. No kēia, ma kahi o ka hahai ʻana i kahi meaʻai haʻahaʻa-liʻiliʻi a me ka hoʻomaʻamaʻa kino kino maʻamau, pono e lawe i nā lāʻau kūpono.

Ua hoʻokaʻawale ʻia nā lāʻau lapaʻau no ka mālama ʻana i ka maʻi diabetes i nā pūʻulu nui.

Nā hua palapala o nā sulfonylureas

Aia kēia mau maʻi diabetes i kahi hopena hypoglycemic ma muli o ka hoʻolahaʻana i nā pū beta e kuleana no ka hana ʻana o ka insulin i ka pancreas. ʻO nā manaʻo o kēia hui e hōʻemi i ka hopena o ka hana renal impaired a me ke kūkulu ʻana o nā maʻi cardiovascular.

Maninil - pono pāʻai no nā maʻi maʻi

ʻO ka papa inoa o nā mea maikaʻi loa o ka sulfonylurea:

Meglitinides

ʻO nā lāʻau lapaʻau no nā maʻi maʻi o kēia pūʻulu e like me ka hopena therapeutic i nā derivatives sulfanilurea a hoʻoulu i ka hana o ka insulin. Aia ko lākou mākaʻi i ke kō koko.

Pono ʻia ka Novonorm no ka hana ʻana o ka insulin

Nā papa inoa o nā meglitinides maikaʻi:

I ka mālamaʻana i ka maʻi diabetes-dependantine, ʻaʻole i hoʻohana ʻia ka meglitinides.

ʻO nā lāʻau lapaʻau o kēia hui e pale i ka hoʻokuʻu ʻana i ka pehu mai ka puʻuwai a kōkua i kona maikaʻi o ka hoʻoliʻi ʻana i nā kiko o ke kino.

ʻO kahi lāʻau lapaʻau no ka uptake glucose maikaʻi aʻe

ʻO nā biguanides maikaʻi loa:

Thiazolidinediones

Hoʻohālikelike lākou e nā hopena like ʻole ma ke kino e like me ka biguanides. ʻO ka ʻokoʻa nui ka uku kiʻekiʻe a me kahi papa inoa o nā hopena.

He kumukūʻai hoʻohuihui momona maikaʻi a maikaʻi

E pili ana kēia:

ʻAʻole he hopena maikaʻi ʻo Thiazolidinediones i ka mālama ʻana i ka mellitus type type 1.

ʻO nā lāʻau hou o ka hanauna hou e kōkua ai e hoʻonui i ka hana o ka insulin a hoʻokuʻu i ke kō mai ka momona.

Pono ʻo Galvus e hoʻokuʻu i ke kō mai ka paʻakai

ʻO ka papa inoa o nā glyptins kūpono:

ʻO Jasonvia e hoʻohaʻahaʻa i ka glucose koko

Hōʻikeʻike Alpha - Glucosidases

Ke pale aku nei kēia mau ʻāpana antidiabetic i ka hana ʻana o kahi enzyme e hoʻohemo ana i nā hoʻokaʻina paʻakikī, a laila e hōʻemi ana i ka nui o ke kahe ʻana o nā polysaccharides. Hōʻike ʻia nā inhibitors e kahi liʻiliʻi o nā hopena ʻona a palekana i ke kino.

E pili ana kēia:

Hiki ke lawe ʻia nā lāʻau lapaʻau i luna e hui pū me nā lāʻau lapaʻau o nā hui ʻē aʻe a me ka insulin.

ʻO Sodium - nā mea paʻa cotransporter inhibitors

ʻO ka hanauna hou o ka lāʻau lapaʻau e hoʻohaʻahaʻa i ke kō hānai koko. ʻO nā lāʻau lapaʻau o kēia pūʻulu e hoʻoulu i nā keiki i ka excrete glucose me ka urine i ka manawa kahi o ka neʻe ai o ke kō i loko o ke koko mai 6 a 8 mmol / l.

ʻO ka hana kumu no ka hoʻohaʻahaʻa i ke kō koko

Ka papa inoa o nā Glyphlosins kūpono:

ʻO nā lāʻau hoʻohui

Nā lāʻau lapaʻau e komo ai i ka metformin a me nā glyptins. ʻO ka papa inoa o nā ala maikaʻi loa o ke ʻano hui like.

Mai lawe i nā lāʻau lapaʻau hui ʻole - hoʻāʻo e hāʻawi i ka makemake i nā biguanides e palekana pono.

Hoʻohui hui pūpū

ʻO ka insulin a me nā peni paha - ʻoi aku ka maikaʻi o ka maʻi diabetes?

Ma ka mālama ʻana i ka maʻi mellitus type 1, ua hoʻohana ʻia ka insulin, ka mālama ʻana o ka maʻi ʻalani like 2 no kahi ʻano hoʻohālike.

Loaʻa nā pōmaikaʻi o nā papa i hoʻohālikelike ʻia:

• mālie o ka hoʻohana ʻana a me ka waiho ʻana,
• ka nele ʻole o ka makaʻu ʻole i ka wā e hoʻokipa ai,
• ka hoʻomehana ʻana o ka hormone kūlohelohe.

ʻO nā pono o nā inikini insulin he hopena therapeutic wikiwiki a me ka hiki ke koho i nā ʻano insulin e kūpono loa no ka mea maʻi.

Ke hoʻohana ʻia nei nā inikina Insulin e nā mea maʻi me ka diabetes mellitus type 2 inā ʻaʻole i hāʻawi maikaʻi ʻia ka lāʻau lapaʻau i ka hopena maikaʻi a ma hope o ka ʻai ʻana i ke kiʻekiʻe o ka glucose i 9 mmol / L.

Hoʻokomo nā injections Insulin inā ʻaʻole kōkua nā peni

“Ua hoʻomanawanui au i ka maʻi maʻamau i ka maʻi maʻamau no nā makahiki he 3. E hoʻolaʻa i nā kōnohi o ke koko, i ka hoʻohui ʻana i ka inane o ka insulin, lawe wau i nā papa Metformin. ʻO wau hoʻi, ʻo ka lāʻau maikaʻi loa kēia no ka maʻi maʻi ma ka uku kumukūʻai. Ke inu nei kekahi hoa i kēia lāʻau lapaʻau ma ka hana e mālama i ka maʻi diabetes type 2 a hauʻoli ʻo ia i ka hopena. ”

"Ua loaʻa iaʻu nā maʻi diabetes 2 like ʻole, aʻu i mālama ai i mau makahiki he nui me ka lāʻau lapaʻau ʻo Iāvia, a laila no Glucobaya. I ka wā mua, ua kōkua kēia mau paila iaʻu, akā naʻe, ua pōʻino koʻu kūlana. Ke hoʻololi nei wau i ka insulin - ua holo ke kō i ke kōʻaiʻai i 6 mmol / l. Hele nō wau a ʻai a komo i nā hāpala. ”

"E like me nā hopena o nā hoʻokolohua, hōʻike ʻia ke kauka he loaʻa kahi kō koko nui koʻu. ʻO ka mālama ʻaina ʻana, ka ʻaina, a me Miglitol. Ua inu wau i ka lāʻau lapaʻau no 2 mau mahina i kēia manawa - ua hoʻi ka pae glucose i ka maʻamau, ua holomua koʻu olakino ākea. ʻO nā pai maikaʻi, akā liʻiliʻi kekahi noʻu. ”

ʻO ka hui pūʻana o kahi meaʻai haʻahaʻa-haʻahaʻa me ka hana a me ka lāʻau kūpono e kōkua i ka hoʻopaʻa ʻana i ke kōpaʻa koko i ke kōpaʻa type 2.

I ka haʻalele ʻana o nā hoʻopiʻi ʻana, hāʻawi i ka makemake i nā lāʻau lapaʻau e komo ai i ka metformin - ke hoʻokū nei lākou i nā pae o ka glucose me nā hopena liʻiliʻi. ʻO ka helu ʻana a me ka pinepine o nā inikini o ka insulin i ka maʻi ʻano 1 e helu ʻia e ke kauka, me ka noʻonoʻo ʻana i nā hiʻohiʻona pilikino o ka maʻi o ka mea maʻi.

Heluhelu i kēia ʻatikala
(2 loio, waena 5,00 noloko mai o 5)

Nā ʻano o nā lāʻau lapaʻau e hoʻohaʻahaʻa i ke kōpaʻa koko

Hoʻokaʻawale ʻia nā paila e hōʻemi i ke kō o ke koko i nā nui nui e like me ke kumuhana o ka hana. Hoʻohana ʻia kēia mau lāʻau lapaʻau:

1. Nā keʻena hōʻike - hoʻihoʻi ikaika i ka insulin mai i nā ʻoihana pancreatic. Huke koke lākou i ke kō koko. Ua hoʻokaʻawale ʻia lākou ma nā derivatives sulfonylurea (Hymepiride, Glycvidon, Glibenclamide) a me nā methyl glinides (Nateglinide, Repaglinide)
2. Nā Sensitizers - hoʻonui i ka ʻike o nā ʻoniho pelipina kūikawā i nā hopena o ka insulin. Ua hoʻokaʻawale ʻia lākou ma biguanides (metformin) a me thiazolidones (pioglitazone).
3. ʻO nā inhibitors o Alpha-glucosidase - hoʻopili i ka hoʻopili ʻana o ka insulin i nā wahi kikoʻī o ka pāpaʻi ʻana. Hoʻohana ʻia lākou i ka mālama paʻakikī o ka maʻi diabetes. Loaʻa ka Acarobase i kēia hui.
4. ʻO nā lāʻau hou o ka hanauna hou - e pili ana i ka iwi adipose, hoʻonui i ka hoʻohuihuiʻana o ka insulin endogenous. ʻO kahi hiʻohiʻona maikaʻi loa ʻo Lyraglutide.
5. Nā lāʻau lapaʻau lāʻau - hoʻokomo i nā kumuwaiwai o ka mulberry, cinnamon, nā ʻaka, nā blueberries.

Sulfonylureas

ʻO nā lāʻau lapaʻau no ka hoʻohaʻahaʻa i ke kō o ke koko mai ka hui derivatives sulfonylurea e hoʻihoʻi i ka hoʻokuʻu ʻana i ka insulin i ke koko, e hoʻohaʻahaʻa ana i ka pae o ka glycemia. Hoʻokumu ke kumuhana o ka hana i ka hoʻoulu ʻana o ka huna huna i ka insulin, e hoʻohaʻahaʻa ana i ka paepae no ka pancreatic beta-cell glucose irritation. ʻO nā hoʻohālikelike i ka hoʻohana ʻana i nā lāʻau lapaʻau nā:

• hypersensitivity i nā ʻāpana o ka pūnao,
• maʻi diabetes type 1
• ketoacidosis, precoma, coma,
• kūlana ma hope o ka haʻalele ʻana o ka pancreatic,
• leukopenia, pūpū o ka ʻōpū,
• ʻoki ʻoki
• hapai, lactation.

Kuhi ʻia nā papa no ka hoʻohana waha. ʻO ka maʻa mua he 1 mg i kēlā me kēia lā, ʻo kēlā me kēia mau hebedoma 1-2 e hoʻonui ʻia ai ka 2, 3 a i ʻole 4 mg mau lā, akā, ʻaʻole iʻoi aku ma mua o 6 mg i kēlā me kēia lā, holoi ʻia me ka hapalua o ka wai o ka wai. Hiki ke hoʻohui ʻia nā hua o nā sulfonylureas me ka insulin, metformin. Pono ka lōʻihi o ka mālamaʻana. ʻO nā hopena ʻaoʻao o nā lāʻau lapaʻau: hypoglycemia, nausea, luaʻi, jaundice, hepatitis, thrombocytopenia. I ka wā o ka maʻi maʻi, nā maʻi kūloko, nā rashes ʻili, ka hōʻeha pū ʻana, hiki i ka photosensitivity. Kūkū ʻia nā o ka sulfonylureas:

Thiazolindione

ʻO nā lāʻau lapaʻau no ka hoʻohaʻahaʻa i ke koko koko mai ka pūʻulu thiazolinedione i nā glitazones, e hōʻemi ana i ka pale ʻana i ka insulin, a me ka hana selly i nā receptors gamma. Ke alakaʻi nei kēia i kahi hoʻoemi i ka glucogenesis ma loko o ka ate, hoʻomaikaʻi i ka mana glycemic. Contraindicated nā lāʻau i ka palaleka o ka kō, ka hapai, ka hōʻoki ʻana, ka maʻi ketoacidosis maʻi.

ʻO ka lawe ʻana i nā lāʻau lapaʻau i ʻoi aku ka lōʻihi o ka makahiki i ka lālani he pōʻino no ka mea hoʻonāukiuki lākou i ke ʻano o nā tumors. Kuhi ʻia nā papa no ka hoʻoponopono waha i ka lā hoʻokahi, me ka manaʻo ʻole o ka ʻaina. ʻO ka dosis mua he 15-30 mg, hoʻonui pinepineʻia i 45 mg. ʻO kā lākou ʻaoʻao ʻaoʻao ke kīwaha i nā hana ate, ka hepatitis, ka ʻike aniani, ka ʻōpū, ka anemia, sinusitis, a me ka nui o ka ʻupena. Aia nā waihona kālā:

ʻO nā mea hoʻonani alpha Glucosidase

ʻO nā lāʻau lapaʻau no ka hoʻohaʻahaʻa i ke kō o ke koko mai ka hui o alpha-glucosidase inhibitors he hypoglycemic hopena ma muli o ke kaohi ʻana o ka puna alpha-glucosidases. Hoʻopuka kēia mau huakaʻi i ka saccharides, e alakaʻi ana i ka hoʻolohi i ka hoʻoliʻi o nā mai o nā kalapona a me ka glucose, ka hoʻemi ʻana o ka awelika a me nā holi i kēlā me kēia lā i ke kō koko. Contraindicated nā papa i ka hihia o ka hypersensitivity i nā mea o ka pūnao, nā maʻi ʻōpū o ke akekelē, nā maʻi o Romgeld, nā hernias nui, nā ʻāwili a me nā ʻōpū o ka ʻōpū, ma lalo o nā makahiki he 18 o ka wā hapai, ka lactation.

Lawe ʻia nā ʻai ma mua o ka ʻai, holoi ʻia me ka nui o nā ʻano wai. ʻO ka pākaukau ma mua he ½-1 papa 1-3 mau manawa, a laila e piʻi i 1-2 papa ʻekolu mau manawa i ka lā. ʻO nā hopena ʻaoʻao o nā lāʻau lapaʻau ka pancreatitis, dyspepsia, ka nui o ka hana o nā enzymes ate. Means ka:

Nā ʻōwili Incretinomimetics

ʻO nā haʻahaʻa hoʻohiolo ʻana i ka wai no ka maʻi type o ke kaila haʻahaʻa 2. Kuhi ʻia nā subspecies o nā mimetin mimikini i ka papa a me ke kēkahi (peni syringes) ʻano. Hoʻokomo i kā lākou mea hana i ka islet apparatus o ka pancreas, sellyly pale i kekahi mau enzyme, e hoʻonui ana i ka huna ʻana o ka peptide like-glucan. Hoʻonui kēia i nā mea huna glucose-hilinaʻi o ka insulin, ka pancreas, a me kahi hoʻohaʻahaʻa i ka pale ʻana i ka insulin.

Hoʻohana wale ʻia nā lāʻau lapaʻau wale nō no ka maʻi maʻi type 2. Ua hoʻohālikelike lākou i ka hihia o ka hypersensitivity i nā māhele o ka mea hoʻohui, a 18 mau makahiki. Hoʻohana ʻia ka hoʻohana me ka makaʻala i nā hōʻeha koʻikoʻi o ka nui o ka ate, ka ulu ʻana o ka galactose hereditary. No ka maʻi maʻamau, e hōʻike ʻia ka 50-100 mg i kēlā me kēia lā, no ka maʻi maʻi maʻa, 100 mg i kēlā me kēia lā. Inā emi iki ka nui o ka dosis ma kahi o 100 mg - lawe ʻia i hoʻokahi manawa i ke kakahiaka, inā 'ole - i ʻelua iniha i ke kakahiaka a i ke ahiahi.

ʻAʻole i hoʻokumu ʻia i ka lāʻau lapaʻau e pili i ka ulu a me ka hoʻomohala ʻana o ka pūpū, no laila ʻaʻole pono ke lawe iā lākou i ka wā hāpai a lactation paha. ʻO nā hopena ʻaoʻao: hepatitis, jaundice cholestatic, nausea, luaʻi, dyspepsia. ʻO nā huahana huahana maʻamau i kēia kulana: